BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8164030)

  • 21. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
    Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
    Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
    Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
    Blood; 1995 Dec; 86(12):4446-53. PubMed ID: 8541533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
    Voils SA; Harpe SH; Brophy GM
    Pharmacotherapy; 2007 Apr; 27(4):535-41. PubMed ID: 17381380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.
    Osterborg A; Brandberg Y; Molostova V; Iosava G; Abdulkadyrov K; Hedenus M; Messinger D;
    J Clin Oncol; 2002 May; 20(10):2486-94. PubMed ID: 12011126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.
    Matsui H; Shiraishi N; Yasuda T; Nezuka T
    Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
    Kunikane H; Watanabe K; Fukuoka M; Saijo N; Furuse K; Ikegami H; Ariyoshi Y; Kishimoto S
    Int J Clin Oncol; 2001 Dec; 6(6):296-301. PubMed ID: 11828949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
    Fischl M; Galpin JE; Levine JD; Groopman JE; Henry DH; Kennedy P; Miles S; Robbins W; Starrett B; Zalusky R
    N Engl J Med; 1990 May; 322(21):1488-93. PubMed ID: 2186273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study.
    Morishima Y; Ogura M; Yoneda S; Sakai H; Tobinai K; Nishiwaki Y; Minami H; Hotta T; Ezaki K; Ohe Y; Yokoyama A; Tsuboi M; Mori K; Watanabe K; Ohashi Y; Hirashima K; Saijo N;
    Jpn J Clin Oncol; 2006 Oct; 36(10):655-61. PubMed ID: 16987908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
    Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
    J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
    Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
    Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant Human Erythropoietin (rHuEPO) for the Treatment of the Anemia of Cancer.
    Abels RI; Larholt KM; Krantz KD; Bryant EC
    Oncologist; 1996; 1(3):140-150. PubMed ID: 10387980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
    Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
    Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
    Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial.
    Bernabeu-Wittel M; Romero M; Ollero-Baturone M; Aparicio R; Murcia-Zaragoza J; Rincón-Gómez M; Monte-Secades R; Melero-Bascones M; Rosso CM; Ruiz-Cantero A;
    Transfusion; 2016 Sep; 56(9):2199-211. PubMed ID: 27195774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N; Fouda M
    Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.